FT’s Endpoints News Deal Puts Pressure on Biopharma Information Providers

$99.00
With deep pockets, FT could accelerate Endpoints News’ product development efforts around content, events, and data to pressure Questex, BioCentury, STAT, and Citeline. There are also essential actions for sellers looking beyond private equity to corporate buyers.

Learn more on the Outsell Leadership Community Platform: FT’s Endpoints News Deal Puts Pressure on Biopharma Information Providers

Author: Randy Giusto

Date: May 2, 2023